GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 Diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019 [published correction appears in Lancet. 2020;396(10262):1562]. Lancet. 2020;396(10258):1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9.
Google Scholar
GBD 2016 Lower Respiratory Infections Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower Respiratory Infections in 195 countries, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191–210. https://doi.org/10.1016/S1473-3099(18)30310-4.
Google Scholar
Savic M, Penders Y, Shi T, Branche A, Pirçon JY. Respiratory syncytial virus Disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031. https://doi.org/10.1111/irv.13031. Epub 2022 Nov 11. PMID: 36369772; PMCID: PMC9835463.
Google Scholar
Rios Guzman E, Hultquist JF. Clinical and biological consequences of respiratory syncytial virus genetic diversity. Ther Adv Infect Dis. 2022;9:20499361221128091. https://doi.org/10.1177/20499361221128091. PMID: 36225856; PMCID: PMC9549189.
Google Scholar
Lin GL, Golubchik T, Drysdale S, O’Connor D, Jefferies K, Brown A, de Cesare M, Bonsall D, Ansari MA, Aerssens J, Bont L, Openshaw P, Martinón-Torres F, Bowden R, Pollard AJ, RESCEU Investigators. Simultaneous viral whole-genome sequencing and Differential expression profiling in respiratory syncytial virus Infection of infants. J Infect Dis. 2020;222(Suppl 7):S666–71. https://doi.org/10.1093/infdis/jiaa448. PMID: 32702120.
Google Scholar
Rodgers L, Sheppard M, Smith A, Dietz S, Jayanthi P, Yuan Y, Bull L, Wotiz S, Schwarze T, Azondekon R, Hartnett K, Adjemian J, Kirking HL, Kite-Powell A. Changes in Seasonal Respiratory illnesses in the United States during the Coronavirus Disease 2019 (COVID-19) pandemic. Clin Infect Dis. 2021;73(Suppl 1):110–S117. https://doi.org/10.1093/cid/ciab311. PMID: 33912902; PMCID: PMC8135472.
Google Scholar
Hamid S, Winn A, Parikh R, Jones JM, McMorrow M, Prill MM, Silk BJ, Scobie HM, Hall AJ. Seasonality of respiratory Syncytial Virus – United States, 2017–2023. MMWR Morb Mortal Wkly Rep. 2023;72(14):355–61. https://doi.org/10.15585/mmwr.mm7214a1. PMID: 37022977; PMCID: PMC10078848.
Google Scholar
Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418–23. Epub 2021 May 12. PMID: 33991720; PMCID: PMC8114587.
Google Scholar
Pizzorno A, Padey B, Dulière V, Mouton W, Oliva J, Laurent E, Milesi C, Lina B, Traversier A, Julien T, Trouillet-Assant S, Rosa-Calatrava M, Terrier O. Interactions between severe Acute Respiratory Syndrome Coronavirus 2 replication and major respiratory viruses in human nasal epithelium. J Infect Dis. 2022;226(12):2095–104. https://doi.org/10.1093/infdis/jiac357. PMID: 36031537; PMCID: PMC9452145.
Google Scholar
Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, detection, and New options for Prevention and Treatment. Clin Microbiol Rev. 2016;30:277–319.
Google Scholar
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, et al. Nirsevimab for Prevention of RSV in healthy late-preterm and term infants. N Engl J Med. 2022;386:837–46.
Google Scholar
Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, et al. Bivalent Prefusion F vaccine in pregnancy to prevent RSV Illness in infants. N Engl J Med. 2023;388:1451–64.
Google Scholar
Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, et al. Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults. N Engl J Med. 2023;388:1465–77.
Google Scholar
Falsey AR, Williams K, Gymnopoulou E, Bart S, Ervin J, Bastian AR, et al. Efficacy and safety of an Ad26.RSV.preF–RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609–20.
Google Scholar
Papi A, Ison MG, Langley JM, Lee D-G, Leroux-Roels I, Martinon-Torres F, et al. Respiratory Syncytial Virus Prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595–608.
Google Scholar
Venkatesan P. First RSV vaccine approvals. The Lancet Microbe. 2023;4:e577.
Google Scholar